Fifteen-Year National Trends in Single-Fraction Stereotactic Body Radiation Therapy Utilization for Stage I Non–Small Cell Lung Cancer
Utilization of SF-SBRT for stage I NSCLC is increasing, particularly at high-volume and/or academic centers. Yet, its overall utilization remains low despite evidence supporting its safety and efficacy.
Authors
- Jie Deng (ORCID: https://orcid.org/0000-0003-0249-1969)
- Michael Xiang (ORCID: https://orcid.org/0000-0003-0170-9321)
- Alan J. Lee (ORCID: https://orcid.org/0000-0002-9527-9563)
- Gregory M.M. Videtic (ORCID: https://orcid.org/0000-0002-6276-1505)
- Drew Moghanaki (ORCID: https://orcid.org/0000-0002-5129-2184)
- Diana Lin Gage (ORCID: https://orcid.org/0009-0004-2686-8163)
- Shankar Siva (ORCID: https://orcid.org/0000-0003-2840-0658)
- Anurag K. Singh (ORCID: https://orcid.org/0000-0002-6703-5115)
Institutions
- Roswell Park Comprehensive Cancer Center (US)
- Cleveland Clinic (US)
- University of California, Los Angeles (US)
- Peter MacCallum Cancer Centre (AU)
- VA Greater Los Angeles Healthcare System (US)
Publication Details
- Journal
- JCO Oncology Practice
- Published
- 2025-12-09
- DOI
- https://doi.org/10.1200/op-25-00826
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00